{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:52:35Z","timestamp":1792896755720,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017346","name":"Boehringer Ingelheim Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017346","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Catechol-<jats:italic>O<\/jats:italic>-methyltransferase (COMT), a magnesium (Mg)-dependent enzyme, metabolises catecholamines. Diabetic patients exhibit hypomagnesemia and sympathetic overactivity compared with non-diabetics. Sodium\u2013glucose cotransporter 2 (SGLT2) inhibitors increase serum Mg levels in diabetic patients. Sympathetic overactivity is associated with diabetic complications; however, the entire mechanism has not been elucidated. Type 2 diabetes model BKS<jats:sup>\n              <jats:italic>db\/db<\/jats:italic>\n            <\/jats:sup> male mice were fed either a control or an empagliflozin-supplemented diet. Mg<jats:sup>2+<\/jats:sup> concentrations, catecholamines, and COMT activity and protein levels were measured. Human Kupffer cells (hKCs) were incubated with norepinephrine (NE) and normetanephrine (NMN), and interleukin (IL)-6 concentrations were quantified. In non-diabetic mice, Mg<jats:sup>2+<\/jats:sup> deficiency was associated with decreased liver COMT activity. In diabetic mice, empagliflozin, an SGLT2 inhibitor, increased plasma Mg<jats:sup>2+<\/jats:sup> levels and elevated the hepatic NMN\/(NE\u2009+\u2009NMN) ratio. Liver COMT activity was suppressed in diabetic mice; however, empagliflozin restored COMT activity without altering COMT protein expression. Empagliflozin ameliorated fibrosis and IL-6 levels in the liver. In hKCs, NE stimulated IL-6 production, which was attenuated by NMN preincubation. We demonstrated that SGLT2 inhibitors regulate sympathetic activity by enhancing COMT activity in diabetic mice. These findings suggest a new potential health benefit of SGLT2 inhibitors.<\/jats:p>","DOI":"10.1038\/s41598-025-12813-x","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T18:55:31Z","timestamp":1753556131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Empagliflozin reduces liver fibrosis by restoring catechol-O-methyltransferase activity associated with magnesium levels"],"prefix":"10.1038","volume":"15","author":[{"given":"Yoshihiro","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kumashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Koya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Kanasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"12813_CR1","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman, B. et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N. Engl. J. Med. 373, 2117\u20132128. https:\/\/doi.org\/10.1056\/NEJMoa1504720 (2015).","journal-title":"N. Engl. J. Med."},{"key":"12813_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","volume":"380","author":"SD Wiviott","year":"2019","unstructured":"Wiviott, S. D. et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N. Engl. J. Med. 380, 347\u2013357. https:\/\/doi.org\/10.1056\/NEJMoa1812389 (2019).","journal-title":"N. Engl. J. Med."},{"key":"12813_CR3","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink, H. J. L. et al. Dapagliflozin in Patients with Chronic Kidney Disease. N. Engl. J. Med. 383, 1436\u20131446. https:\/\/doi.org\/10.1056\/NEJMoa2024816 (2020).","journal-title":"N. Engl. J. Med."},{"key":"12813_CR4","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer, M. et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N. Engl. J. Med. 383, 1413\u20131424. https:\/\/doi.org\/10.1056\/NEJMoa2022190 (2020).","journal-title":"N. Engl. J. Med."},{"key":"12813_CR5","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/01.hyp.21.5.618","volume":"21","author":"KA Jamerson","year":"1993","unstructured":"Jamerson, K. A., Julius, S., Gudbrandsson, T., Andersson, O. & Brant, D. O. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 21, 618\u2013623. https:\/\/doi.org\/10.1161\/01.hyp.21.5.618 (1993).","journal-title":"Hypertension"},{"key":"12813_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.diabres.2008.09.054","volume":"83","author":"VP Jyotsna","year":"2009","unstructured":"Jyotsna, V. P., Sahoo, A., Sreenivas, V. & Deepak, K. K. Prevalence and pattern of cardiac autonomic dysfunction in newly detected type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 83, 83\u201388. https:\/\/doi.org\/10.1016\/j.diabres.2008.09.054 (2009).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"12813_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrn1902","volume":"7","author":"PG Guyenet","year":"2006","unstructured":"Guyenet, P. G. The sympathetic control of blood pressure. Nat. Rev. Neurosci. 7, 335\u2013346. https:\/\/doi.org\/10.1038\/nrn1902 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"12813_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJM198409273111303","volume":"311","author":"JN Cohn","year":"1984","unstructured":"Cohn, J. N. et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311, 819\u2013823. https:\/\/doi.org\/10.1056\/NEJM198409273111303 (1984).","journal-title":"N. Engl. J. Med."},{"key":"12813_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/hr.2010.35","volume":"33","author":"K Masuo","year":"2010","unstructured":"Masuo, K. et al. The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens Res. 33, 521\u2013528. https:\/\/doi.org\/10.1038\/hr.2010.35 (2010).","journal-title":"Hypertens Res."},{"key":"12813_CR10","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.2337\/diabetes.51.12.3524","volume":"51","author":"D Liao","year":"2002","unstructured":"Liao, D., Carnethon, M., Evans, G. W., Cascio, W. E. & Heiss, G. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: The atherosclerosis risk in communities (ARIC) study. Diabetes 51, 3524\u20133531. https:\/\/doi.org\/10.2337\/diabetes.51.12.3524 (2002).","journal-title":"Diabetes"},{"key":"12813_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2337\/db23-0247","volume":"73","author":"Y Tang","year":"2024","unstructured":"Tang, Y. et al. Cardiovascular Autonomic Neuropathy and Risk of Kidney Function Decline in Type 1 and Type 2 Diabetes: Findings From the PERL and ACCORD Cohorts. Diabetes 73, 751\u2013762. https:\/\/doi.org\/10.2337\/db23-0247 (2024).","journal-title":"Diabetes"},{"key":"12813_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jjcc.2017.12.004","volume":"71","author":"M Sano","year":"2018","unstructured":"Sano, M. A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity. J. Cardiol. 71, 471\u2013476. https:\/\/doi.org\/10.1016\/j.jjcc.2017.12.004 (2018).","journal-title":"J. Cardiol."},{"key":"12813_CR13","doi-asserted-by":"publisher","first-page":"i3","DOI":"10.1093\/ndtplus\/sfr163","volume":"5","author":"W Jahnen-Dechent","year":"2012","unstructured":"Jahnen-Dechent, W. & Ketteler, M. Magnesium basics. Clin. Kidney J. 5, i3\u2013i14. https:\/\/doi.org\/10.1093\/ndtplus\/sfr163 (2012).","journal-title":"Clin. Kidney J."},{"key":"12813_CR14","doi-asserted-by":"publisher","first-page":"e24287","DOI":"10.1371\/journal.pone.0024287","volume":"6","author":"D Tsao","year":"2011","unstructured":"Tsao, D., Diatchenko, L. & Dokholyan, N. V. Structural mechanism of S-adenosyl methionine binding to catechol O-methyltransferase. PLoS ONE 6, e24287. https:\/\/doi.org\/10.1371\/journal.pone.0024287 (2011).","journal-title":"PLoS ONE"},{"key":"12813_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/HYPERTENSIONAHA.120.16377","volume":"78","author":"A Kumagai","year":"2021","unstructured":"Kumagai, A. et al. Dietary Magnesium Insufficiency Induces Salt-Sensitive Hypertension in Mice Associated With Reduced Kidney Catechol-O-Methyl Transferase Activity. Hypertension 78, 138\u2013150. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.16377 (2021).","journal-title":"Hypertension"},{"key":"12813_CR16","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1086\/425589","volume":"75","author":"J Chen","year":"2004","unstructured":"Chen, J. et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet. 75, 807\u2013821. https:\/\/doi.org\/10.1086\/425589 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"12813_CR17","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1371\/journal.pone.0000181","volume":"2","author":"S Voutilainen","year":"2007","unstructured":"Voutilainen, S. et al. Functional COMT Val158Met polymorphism, risk of acute coronary events and serum homocysteine: The Kuopio ischaemic heart disease risk factor study. PLoS ONE 2, e181. https:\/\/doi.org\/10.1371\/journal.pone.0000181 (2007).","journal-title":"PLoS ONE"},{"key":"12813_CR18","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ajh.2011.93","volume":"24","author":"NC Htun","year":"2011","unstructured":"Htun, N. C. et al. Association of the catechol-O-methyl transferase gene Val158Met polymorphism with blood pressure and prevalence of hypertension: Interaction with dietary energy intake. Am. J. Hypertens 24, 1022\u20131026. https:\/\/doi.org\/10.1038\/ajh.2011.93 (2011).","journal-title":"Am. J. Hypertens"},{"key":"12813_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","volume":"627","author":"K Suzuki","year":"2024","unstructured":"Suzuki, K. et al. Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature 627, 347\u2013357. https:\/\/doi.org\/10.1038\/s41586-024-07019-6 (2024).","journal-title":"Nature"},{"key":"12813_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2215\/CJN.02960906","volume":"2","author":"PC Pham","year":"2007","unstructured":"Pham, P. C., Pham, P. M., Pham, S. V., Miller, J. M. & Pham, P. T. Hypomagnesemia in patients with type 2 diabetes. Clin. J. Am. Soc. Nephrol. 2, 366\u2013373. https:\/\/doi.org\/10.2215\/CJN.02960906 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"12813_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.diabet.2015.03.010","volume":"41","author":"F Guerrero-Romero","year":"2015","unstructured":"Guerrero-Romero, F., Simental-Mendia, L. E., Hernandez-Ronquillo, G. & Rodriguez-Moran, M. Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: A double-blind placebo-controlled randomized trial. Diabetes Metab. 41, 202\u2013207. https:\/\/doi.org\/10.1016\/j.diabet.2015.03.010 (2015).","journal-title":"Diabetes Metab."},{"key":"12813_CR22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/qjmed\/hcx186","volume":"111","author":"AAA Ismail","year":"2018","unstructured":"Ismail, A. A. A., Ismail, Y. & Ismail, A. A. Chronic magnesium deficiency and human disease; time for reappraisal?. QJM 111, 759\u2013763. https:\/\/doi.org\/10.1093\/qjmed\/hcx186 (2018).","journal-title":"QJM"},{"key":"12813_CR23","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1007\/s00125-016-4101-6","volume":"59","author":"H Tang","year":"2016","unstructured":"Tang, H. et al. Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: A meta-analysis of randomised controlled trials. Diabetologia 59, 2546\u20132551. https:\/\/doi.org\/10.1007\/s00125-016-4101-6 (2016).","journal-title":"Diabetologia"},{"key":"12813_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13098-016-0169-x","volume":"8","author":"T Jojima","year":"2016","unstructured":"Jojima, T. et al. Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes. Diabetol. Metab. Syndr. 8, 45. https:\/\/doi.org\/10.1186\/s13098-016-0169-x (2016).","journal-title":"Diabetol. Metab. Syndr."},{"key":"12813_CR25","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1053\/j.ajkd.2023.11.006","volume":"83","author":"CV Shah","year":"2024","unstructured":"Shah, C. V., Sparks, M. A. & Lee, C. T. Sodium\/Glucose Cotransporter 2 Inhibitors and Magnesium Homeostasis: A Review. Am. J. Kidney Dis. 83, 648\u2013658. https:\/\/doi.org\/10.1053\/j.ajkd.2023.11.006 (2024).","journal-title":"Am. J. Kidney Dis."},{"key":"12813_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cells11061021","author":"E Lelou","year":"2022","unstructured":"Lelou, E. et al. The Role of Catecholamines in Pathophysiological Liver Processes. Cells https:\/\/doi.org\/10.3390\/cells11061021 (2022).","journal-title":"Cells"},{"key":"12813_CR27","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/hep.21427","volume":"44","author":"N Nieto","year":"2006","unstructured":"Nieto, N. Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected] Kupffer cells on stellate cells. Hepatology 44, 1487\u20131501. https:\/\/doi.org\/10.1002\/hep.21427 (2006).","journal-title":"Hepatology"},{"key":"12813_CR28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1126\/science.132.3424.419","volume":"132","author":"J Champagne","year":"1960","unstructured":"Champagne, J., D\u2019Iorio, A. & Beaulnes, A. Biological activity of 3-methoxy-catecholamines. Science 132, 419\u2013420. https:\/\/doi.org\/10.1126\/science.132.3424.419 (1960).","journal-title":"Science"},{"key":"12813_CR29","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/jdi.13311","volume":"11","author":"Y Mizunuma","year":"2020","unstructured":"Mizunuma, Y. et al. CD-1(db\/db) mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis. J. Diabetes Investig. 11, 1470\u20131481. https:\/\/doi.org\/10.1111\/jdi.13311 (2020).","journal-title":"J. Diabetes Investig."},{"key":"12813_CR30","doi-asserted-by":"publisher","first-page":"578","DOI":"10.21037\/atm.2019.09.70","volume":"7","author":"M Liu","year":"2019","unstructured":"Liu, M., Yang, H. & Mao, Y. Magnesium and liver disease. Ann. Transl. Med.. 7, 578. https:\/\/doi.org\/10.21037\/atm.2019.09.70 (2019).","journal-title":"Ann. Transl. Med.."},{"key":"12813_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000159028","volume":"31","author":"LP Weber","year":"1994","unstructured":"Weber, L. P. & MacLeod, K. M. Contractile responses of caudal arteries from diabetic rats to adrenergic nerve stimulation. J. Vasc. Res. 31, 25\u201332. https:\/\/doi.org\/10.1159\/000159028 (1994).","journal-title":"J. Vasc. Res."},{"key":"12813_CR32","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","volume":"72","author":"EL Cho","year":"2023","unstructured":"Cho, E. L. et al. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: An updated systematic review and meta-analysis. Gut 72, 2138\u20132148. https:\/\/doi.org\/10.1136\/gutjnl-2023-330110 (2023).","journal-title":"Gut"},{"key":"12813_CR33","doi-asserted-by":"publisher","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","volume":"111S","author":"A Mantovani","year":"2020","unstructured":"Mantovani, A. et al. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism 111S, 154170. https:\/\/doi.org\/10.1016\/j.metabol.2020.154170 (2020).","journal-title":"Metabolism"},{"key":"12813_CR34","doi-asserted-by":"publisher","first-page":"11124","DOI":"10.1038\/s41598-019-47687-3","volume":"9","author":"Y Liu","year":"2019","unstructured":"Liu, Y., Zhong, G. C., Tan, H. Y., Hao, F. B. & Hu, J. J. Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: A meta-analysis. Sci. Rep. 9, 11124. https:\/\/doi.org\/10.1038\/s41598-019-47687-3 (2019).","journal-title":"Sci. Rep."},{"key":"12813_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14030153","author":"S Rafaqat","year":"2024","unstructured":"Rafaqat, S., Gluscevic, S., Mercantepe, F., Rafaqat, S. & Klisic, A. Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease. Metabolites https:\/\/doi.org\/10.3390\/metabo14030153 (2024).","journal-title":"Metabolites"},{"key":"12813_CR36","doi-asserted-by":"publisher","first-page":"880298","DOI":"10.3389\/fimmu.2022.880298","volume":"13","author":"Y Duan","year":"2022","unstructured":"Duan, Y. et al. Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease. Front. Immunol. 13, 880298. https:\/\/doi.org\/10.3389\/fimmu.2022.880298 (2022).","journal-title":"Front. Immunol."},{"key":"12813_CR37","doi-asserted-by":"publisher","first-page":"1199519","DOI":"10.3389\/fcell.2023.1199519","volume":"11","author":"GX Xu","year":"2023","unstructured":"Xu, G. X. et al. Activation of Kupffer cells in NAFLD and NASH: Mechanisms and therapeutic interventions. Front. Cell Dev. Biol. 11, 1199519. https:\/\/doi.org\/10.3389\/fcell.2023.1199519 (2023).","journal-title":"Front. Cell Dev. Biol."},{"key":"12813_CR38","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","volume":"103","author":"A Wieckowska","year":"2008","unstructured":"Wieckowska, A. et al. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am. J. Gastroenterol. 103, 1372\u20131379. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01774.x (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"12813_CR39","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1113\/JP281061","volume":"600","author":"DR Kamm","year":"2022","unstructured":"Kamm, D. R. & McCommis, K. S. Hepatic stellate cells in physiology and pathology. J. Physiol. 600, 1825\u20131837. https:\/\/doi.org\/10.1113\/JP281061 (2022).","journal-title":"J. Physiol."},{"key":"12813_CR40","doi-asserted-by":"publisher","first-page":"e0176173","DOI":"10.1371\/journal.pone.0176173","volume":"12","author":"P Kagan","year":"2017","unstructured":"Kagan, P., Sultan, M., Tachlytski, I., Safran, M. & Ben-Ari, Z. Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation. PLoS ONE 12, e0176173. https:\/\/doi.org\/10.1371\/journal.pone.0176173 (2017).","journal-title":"PLoS ONE"},{"key":"12813_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0925-4439(01)00055-2","volume":"1537","author":"M Zhou","year":"2001","unstructured":"Zhou, M. et al. The role of Kupffer cell alpha(2)-adrenoceptors in norepinephrine-induced TNF-alpha production. Biochim. Biophys. Acta 1537, 49\u201357. https:\/\/doi.org\/10.1016\/s0925-4439(01)00055-2 (2001).","journal-title":"Biochim. Biophys. Acta"},{"key":"12813_CR42","doi-asserted-by":"publisher","first-page":"e5504","DOI":"10.1371\/journal.pone.0005504","volume":"4","author":"M Miksa","year":"2009","unstructured":"Miksa, M. et al. Pivotal role of the alpha(2A)-adrenoceptor in producing inflammation and organ injury in a rat model of sepsis. PLoS ONE 4, e5504. https:\/\/doi.org\/10.1371\/journal.pone.0005504 (2009).","journal-title":"PLoS ONE"},{"key":"12813_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MNH.0000000000000199","volume":"25","author":"I Tikkanen","year":"2016","unstructured":"Tikkanen, I., Chilton, R. & Johansen, O. E. Potential role of sodium glucose cotransporter 2 inhibitors in the treatment of hypertension. Curr. Opin. Nephrol. Hypertens 25, 81\u201386. https:\/\/doi.org\/10.1097\/MNH.0000000000000199 (2016).","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"12813_CR44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11886-019-1165-1","volume":"21","author":"AJ Scheen","year":"2019","unstructured":"Scheen, A. J. Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure. Curr. Cardiol. Rep. 21, 70. https:\/\/doi.org\/10.1007\/s11886-019-1165-1 (2019).","journal-title":"Curr. Cardiol. Rep."},{"key":"12813_CR45","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.brainresbull.2011.11.012","volume":"88","author":"AV Witte","year":"2012","unstructured":"Witte, A. V. & Floel, A. Effects of COMT polymorphisms on brain function and behavior in health and disease. Brain Res. Bull. 88, 418\u2013428. https:\/\/doi.org\/10.1016\/j.brainresbull.2011.11.012 (2012).","journal-title":"Brain Res. Bull."},{"key":"12813_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nm1166","volume":"11","author":"D Cai","year":"2005","unstructured":"Cai, D. et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11, 183\u2013190. https:\/\/doi.org\/10.1038\/nm1166 (2005).","journal-title":"Nat. Med."},{"key":"12813_CR47","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1006\/abio.1999.4043","volume":"269","author":"M Tsunoda","year":"1999","unstructured":"Tsunoda, M., Takezawa, K., Santa, T. & Imai, K. Simultaneous automatic determination of catecholamines and their 3-O-methyl metabolites in rat plasma by high-performance liquid chromatography using peroxyoxalate chemiluminescence reaction. Anal. Biochem. 269, 386\u2013392. https:\/\/doi.org\/10.1006\/abio.1999.4043 (1999).","journal-title":"Anal. Biochem."},{"key":"12813_CR48","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1021\/ac0003697","volume":"72","author":"K Takezawa","year":"2000","unstructured":"Takezawa, K., Tsunoda, M., Watanabe, N. & Imai, K. An automatic analyzer for catecholamines and their 3-O-methyl metabolites using a micro coulometric flow cell as a postcolumn reactor for fluorogenic reaction. Anal. Chem. 72, 4009\u20134014. https:\/\/doi.org\/10.1021\/ac0003697 (2000).","journal-title":"Anal. Chem."},{"key":"12813_CR49","doi-asserted-by":"publisher","first-page":"p9","DOI":"10.1159\/000318177","volume":"116","author":"H Iijima","year":"2010","unstructured":"Iijima, H., Okada, Y., Tsunoda, M., Takamiya, T. & Imai, K. Quantification of norepinephrine and its metabolites in the plasma of renal failure models. Nephron. Physiol. 116, p9\u2013p16. https:\/\/doi.org\/10.1159\/000318177 (2010).","journal-title":"Nephron. Physiol."},{"key":"12813_CR50","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1006\/bbrc.1994.2871","volume":"205","author":"QB She","year":"1994","unstructured":"She, Q. B., Nagao, I., Hayakawa, T. & Tsuge, H. A simple HPLC method for the determination of S-adenosylmethionine and S-adenosylhomocysteine in rat tissues: The effect of vitamin B6 deficiency on these concentrations in rat liver. Biochem. Biophys. Res. Commun. 205, 1748\u20131754. https:\/\/doi.org\/10.1006\/bbrc.1994.2871 (1994).","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12813-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12813-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12813-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T08:21:41Z","timestamp":1753690901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12813-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12813"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12813-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27310"}}